-
Thematic Analysis
Cell and Gene Therapies in Rheumatology - Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies in Rheumatology Market Report Overview The market size for cell and gene therapies (CGT) in rheumatic diseases by molecule type is estimated to be $24 million in 2024. Cell therapies will continue to dominate the CGT market in rheumatic diseases. This growth is attributed to the high number of cell therapy assets in the pipeline and increasing interest in rheumatic diseases due to the increasing prevalence and high unmet need, especially as the aging population increases....
-
Sector Analysis
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2031
Osteoarthritis Market Overview The osteoarthritis market size was valued at $2.5 billion in 2021 and is expected to achieve a CAGR of more than 4% during 2021-2031. OA is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. Contrary to the previous notion that OA is exclusively a disorder of articular cartilage, studies have demonstrated it is a disease of the whole joint, adversely affecting the subchondral bone,...
-
Sector Analysis
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
Osteoarthritis (OA) market size was 18,820,737 cases in 2021 cases across 7MM. The market is expected to grow at an AGR of more than 1% during the forecast period. The osteoarthritis epidemiology market research report provides an overview of the risk factors, comorbidities, and global and historical trends for hand OA, knee OA, and hip OA in the seven major markets or 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.